Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PACB | TMO | ISRG | EW | IDXX |
| Company | Pacific Biosciences | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Idexx Laboratories |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.3700 | 577.40 | 374.12 | 88.00 | 494.82 |
| High | 1.4200 | 577.99 | 374.87 | 88.00 | 494.82 |
| Low | 1.3000 | 569.98 | 367.66 | 86.66 | 479.88 |
| Last | 1.3150 | 572.40 | 371.30 | 87.75 | 482.01 |
| Change | -0.0450 | -4.99 | -3.71 | -0.86 | -12.25 |
| % Change | -3.31% | -0.86% | -0.99% | -0.97% | -2.48% |
| Volume | 4,704,198 | 561,555 | 499,731 | 1,335,523 | 118,444 |
| 20-Day Average Volume | 12,538,813 | 1,338,066 | 1,580,770 | 2,927,172 | 418,135 |
| Previous Close | 1.3600 | 577.39 | 375.01 | 88.61 | 494.26 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.6063 | 567.86 | 381.55 | 90.48 | 502.95 |
| 20-Day Raw Stochastic | 1.89% | 71.88% | 16.33% | 21.51% | 16.07% |
| 20-Day Relative Strength | 22.55% | 52.34% | 43.45% | 46.15% | 34.97% |
| Weighted Alpha | -86.08 | +7.82 | +23.98 | +6.10 | -3.90 |
| Today's Opinion | 100% Sell | 72% Buy | 40% Buy | 56% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 72% Buy | 40% Buy | 56% Buy | 40% Sell |
| Last Month's Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.96% since 04/18/24 | +5.81% since 04/18/24 | -0.59% since 04/18/24 | +1.43% since 04/18/24 | +1.08% since 04/18/24 |
| Low | 1.3000 on 04/25/24 | 539.17 on 04/19/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 1.6700 on 04/19/24 | 586.46 on 04/24/24 | 388.65 on 04/19/24 | 89.17 on 04/24/24 | 497.40 on 04/24/24 |
| 1-Month | |||||
| %Chg | -63.99% since 03/25/24 | -0.10% since 03/25/24 | -5.43% since 03/25/24 | -5.87% since 03/25/24 | -8.82% since 03/25/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 471.42 on 04/19/24 |
| High | 3.8900 on 03/28/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 543.33 on 03/28/24 |
| 3-Month | |||||
| %Chg | -81.69% since 01/25/24 | +6.46% since 01/25/24 | -1.21% since 01/25/24 | +19.23% since 01/25/24 | -7.55% since 01/25/24 |
| Low | 1.2500 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 72.71 on 01/29/24 | 471.42 on 04/19/24 |
| High | 7.5000 on 01/26/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| 6-Month | |||||
| %Chg | -80.65% since 10/25/23 | +32.27% since 10/25/23 | +38.94% since 10/25/23 | +28.31% since 10/25/23 | +17.03% since 10/25/23 |
| Low | 1.2500 on 04/17/24 | 420.21 on 10/30/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 372.50 on 11/01/23 |
| High | 10.6500 on 12/27/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 583.39 on 03/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 364,415 | 220,397,840 | 133,018,304 | 53,336,752 | 41,050,272 |
| Shares Outstanding, K | 267,952 | 381,714 | 354,706 | 601,927 | 83,054 |
| Annual Sales | 200,520,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,660,950,000 |
| Annual Net Income | -306,740,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 845,040,000 |
| Last Quarter Sales | 58,360,000 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 901,600,000 |
| Last Quarter Net Income | -82,020,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 194,520,000 |
| 60-Month Beta | 1.83 | 0.80 | 1.36 | 1.05 | 1.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 02/15/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 2.32 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.68 | 80.57 | 34.96 | 49.04 |